SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001432093-11-000429
Filing Date
2011-07-08
Accepted
2011-07-07 17:47:11
Documents
1

Document Format Files

Seq Description Document Type Size
1 hillel13gmanhattan.htm SC 13G 77579
  Complete submission text file 0001432093-11-000429.txt   79057
Mailing Address 810 SEVENTH AVENUE 4TH FLOOR NEW YORK NY 10019
Business Address 810 SEVENTH AVENUE 4TH FLOOR NEW YORK NY 10019 (212) 582-3950
MANHATTAN PHARMACEUTICALS INC (Subject) CIK: 0001001316 (see all company filings)

IRS No.: 363898269 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-51051 | Film No.: 11957223
SIC: 2834 Pharmaceutical Preparations

Mailing Address 59 MAIDEN LANE 6TH FLOOR NEW YORK NY 10038
Business Address
Gross Hillel A. (Filed by) CIK: 0001525093 (see all company filings)

Type: SC 13G